The FDA has expanded the approval of tildrakizumab for adults with active psoriatic arthritis, adding to its use for moderate-to-severe plaque psoriasis.
The FDA has expanded the approval of tildrakizumab for adults with active psoriatic arthritis, adding to its use…
Tenet Healthcare raises 2026 earnings guidance by focusing on high-value surgeries, stabilizing finances amid weak surgical market and…
AI models give wrong medication doses in about 2% of cases, Doximity research finds, raising concerns about AI…
Massachusetts judge blocks CMS medical frailty definition exempting Medicaid enrollees from work requirements, a decision reshaping eligibility rules.
UHS cuts 2026 earnings forecast amid surgery decline, outpatient shift.
Zocdoc allows AI to book doctor appointments, marking a contrarian move in the healthcare industry with AI agents…
US simplifies health tech certification process to reduce compliance costs for developers by $1.5 billion.
The US uninsurance rate rises to 11%, up from 8.9% in 2024, according to a new Commonwealth Fund…
Five major companies pledge faster electronic prior authorizations for self-funded health plans.
Healthcare providers urge FDA to hold AI developers accountable for medical device safety, warning monitoring could burden smaller…
